Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)
Conditions: Pleural Mesothelioma Interventions: Drug: Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab Sponsors: Istituto Oncologico Veneto IRCCS; MSD Italia S.r.l. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alimta | Asbestosis | Cancer & Oncology | Immunotherapy | Mesothelioma | Research | Study